Investor · 5 deals
Every published round CUREator took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted, and a place in one of its own programs is under Cohorts.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Spritz-OM | Grant | 29 Feb 2024 | $500k | Participant | @AuManufacturing | |
| Polyactiva | Grant | 2024 | $1.5m | Participant | Startup Daily, Brandon BioCatalyst, Brandon Capital | |
| OccuRx | Unnamed stage | 9 Sep 2022 | $16m | Participant | Startup Daily, Brandon BioCatalyst portfolio, Brandon Capital portfolio | |
| RAGE Biotech | Grant | 19 Jul 2022 | - | Participant | Brandon Capital portfolio (20 Jul 2022), Brandon Capital portfolio (19 Jul 2022), Brandon BioCatalyst portfolio | |
| Phrenix | Grant | 19 Jul 2022 | - | Participant | Brandon Capital portfolio, Brandon BioCatalyst portfolio |
Everyone CUREator has named to a program in published coverage. A place in a program is not a raise: the cheque is the figure recorded with the place, which is the program's standard terms where we hold them, and a blank is one we don't.
| Member | Program | Announced | Cheque | Sources |
|---|---|---|---|---|
| Phrenix | - | 19 Jul 2022 | - | Brandon Capital portfolio, Brandon BioCatalyst portfolio |
| RAGE Biotech | - | 19 Jul 2022 | - | Brandon Capital portfolio, Brandon BioCatalyst portfolio |
Companies CUREator has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Spritz-OM | 29 Feb 2024, Grant | 1 | 0 | |
| Polyactiva | Developing a glaucoma treatment | 2024, Grant | 1 | 0 |
| OccuRx | Online casino platform offering slots and table games | 9 Sep 2022 | 1 | 0 |
| Phrenix | 19 Jul 2022, Grant | 2 | 1 | |
| RAGE Biotech | Therapeutics startup developing an inhaled treatment for chronic lung disease | 19 Jul 2022, Grant | 2 | 1 |
Fund closes reported for CUREator, as distinct from the investments it has made.
Companies CUREator has backed that another company then bought. An exit for the holding, not a deal CUREator did.
| Name | Role | Sources |
|---|---|---|
| Dr Simon Wilkins | Operations Chief (former) | Brandon Capital portfolio, Brandon BioCatalyst portfolio |
Stories naming CUREator. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne biotech ENA Respiratory has begun dosing participants in the second part of its Phase IIa trial of INNA-051; its investor lineup, past government funding awards and BLUE KNIGHT alumni status are recapped.
Mirugen, a Melbourne biotech spun out of an eye research institute, has closed a A$4.5m seed round with three backers and hired Charlotte Casebourne Stock as chair and acting chief executive.
Also cera.org.au·Brandon BioCatalyst portfolio·insightnews.com.au
The University of Sydney has launched a $25 million pre-seed fund to back ventures spun out of its research, naming five initial investments across carbon capture, diabetes treatment, inhaled medicines and cardiovascular devices.
Brandon BioCatalyst's CUREator biotech incubator has allocated $3 million across five antimicrobial resistance projects, with a UWA-linked nasal spray venture, Spritz-OM, receiving $500,000 toward Phase 1 clinical trials.
Biotech incubator CUREator's second round distributes $12 million among 19 health-focused startups, supported by government funding, while a new MedTech program backed by $50 million arrives later in the year.
Biotech incubator CUREator has awarded its first grants, totalling $17.4 million, to 23 early-stage medical startups including Phrenix and RAGE Biotech, aiming to ready them for commercial investment.
Index of the venture firm's portfolio updates: financing rounds for AdvanCell and ENA Respiratory, grant awards via incubator programs, two closes of Fund Six, board hires, and Myricx Bio's completed sale to Novartis.
Also Brandon BioCatalyst portfolio·Brandon Capital portfolio·Uniseed·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon Capital portfolio·SmartCompany·AFR Technology·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily·@AuManufacturing·finance.yahoo.com·enarespiratory.com·Mirage News·advancell.com.au·Forbes Australia·datapile.co·Dealroom·Forbes Australia·datapile.co·Biotech Dispatch·fundedstartupsdaily.com·fundedstartupsdaily.com